Aerie Pharma (AERI) Announces Statistically Significant Data from Roclatan Phase 3 Mercury 1 Trial
Go back to Aerie Pharma (AERI) Announces Statistically Significant Data from Roclatan Phase 3 Mercury 1 TrialAERIE PHARMACEUT (NASDAQ: AERI) | Delayed: 15.25 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $15.25 | 52 Week High | $41.72 | |||
Open | $15.25 | 52 Week Low | $10.82 | |||
Day High | $15.25 | P/E | N/A | |||
Day Low | $15.25 | EPS | $-0.95 | |||
Volume | 55 |